These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 17093459)

  • 1. Rising biotech appetite in the East.
    Sheridan C
    Nat Biotechnol; 2006 Nov; 24(11):1305-6. PubMed ID: 17093459
    [No Abstract]   [Full Text] [Related]  

  • 2. Realizing potential: the state of Asian bioentrepreneurship.
    Tang CM; Mahmud MA; Foo FK; Chu SY; Chiu RI; Tanticharoen M; Zhang L; Chang TW
    Nat Biotechnol; 2003 Jul; 21 Suppl():BE15-22. PubMed ID: 12874972
    [No Abstract]   [Full Text] [Related]  

  • 3. Biotech finance: a family affair.
    Hurwitz EM
    Nat Biotechnol; 1999 Feb; 17 Suppl():BE35-7. PubMed ID: 10052326
    [No Abstract]   [Full Text] [Related]  

  • 4. Biotech rallies in Q3.
    Yang W
    Nat Biotechnol; 2010 Nov; 28(11):1144. PubMed ID: 21057476
    [No Abstract]   [Full Text] [Related]  

  • 5. Delisting threat looms large on biotech front.
    Lawrence S
    Nat Biotechnol; 2005 Jan; 23(1):5. PubMed ID: 15637598
    [No Abstract]   [Full Text] [Related]  

  • 6. Biotech stocks struggle as financial markets tumble.
    Mitchell P
    Nat Biotechnol; 2002 Aug; 20(8):755-6. PubMed ID: 12147984
    [No Abstract]   [Full Text] [Related]  

  • 7. Rainbow biotech--South Africa's emerging sector.
    Louët S
    Nat Biotechnol; 2006 Nov; 24(11):1313-6. PubMed ID: 17093464
    [No Abstract]   [Full Text] [Related]  

  • 8. Investing in nanotechnology.
    Paull R; Wolfe J; Hébert P; Sinkula M
    Nat Biotechnol; 2003 Oct; 21(10):1144-7. PubMed ID: 14520393
    [No Abstract]   [Full Text] [Related]  

  • 9. Commercializing nanotechnology.
    Mazzola L
    Nat Biotechnol; 2003 Oct; 21(10):1137-43. PubMed ID: 14520392
    [No Abstract]   [Full Text] [Related]  

  • 10. Making it in the biotech business.
    Gewin V
    Nature; 2005 May; 435(7038):124-5. PubMed ID: 15875029
    [No Abstract]   [Full Text] [Related]  

  • 11. Biotech believer.
    Mehta SN
    Fortune; 2005 Feb; 151(4):128, 130. PubMed ID: 15729936
    [No Abstract]   [Full Text] [Related]  

  • 12. New biotech hubs may emerge as industry matures.
    Basu P
    Nat Biotechnol; 2003 Oct; 21(10):1123. PubMed ID: 14520385
    [No Abstract]   [Full Text] [Related]  

  • 13. Diversify to multiply.
    Jacobs T
    Nat Biotechnol; 2005 Apr; 23(4):419. PubMed ID: 15815663
    [No Abstract]   [Full Text] [Related]  

  • 14. Financing flees in Q3.
    Lawrence S
    Nat Biotechnol; 2006 Nov; 24(11):1312. PubMed ID: 17093463
    [No Abstract]   [Full Text] [Related]  

  • 15. The preeminence of clusters.
    Bühler F; Tang CM; Shah P; Leuchtenberger M; Lin KC; Pissarra Pde N
    Nat Biotechnol; 2007 Nov; 25(11):1207-9. PubMed ID: 18161071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 2019 biotech IPOs: party on.
    Morrison C
    Nat Rev Drug Discov; 2020 Jan; 19(1):6-9. PubMed ID: 31907435
    [No Abstract]   [Full Text] [Related]  

  • 17. The number on biotech indexes.
    Jacobs T
    Nat Biotechnol; 2005 Nov; 23(11):1356. PubMed ID: 16273059
    [No Abstract]   [Full Text] [Related]  

  • 18. Kiran Mazumdar-Shaw.
    Jayaraman KS
    Nat Biotechnol; 2005 Jan; 23(1):11. PubMed ID: 15637602
    [No Abstract]   [Full Text] [Related]  

  • 19. Australia--the premier Asia-Pacific hub for biotech investment.
    Watkinson N
    Drug Discov Today; 2008 Mar; 13(5-6):192-7. PubMed ID: 18342794
    [No Abstract]   [Full Text] [Related]  

  • 20. Strategic consolidation: the biotechnology business model for the 21st century.
    Esposito RS; Ostro MJ
    Nat Biotechnol; 1999 Feb; 17 Suppl():BE16-7. PubMed ID: 10052317
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.